BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28

• Drug Development

  FDA Lifts Clinical Hold on NW Bio’s Phase III Cancer Vaccine Trial

  February 6, 2017

   · 

  5 min read
• Drug Development

  Another Letdown for Bristol-Myers Squibb as Partner Innate Pharma’s Leukemia Candidate Flunks Phase II Test

  February 6, 2017

   · 

  7 min read
• Lone Star Bio

  RadioMedix Release: First U.S. Multi-Center Investigational Clinical Trial Of 177 Lu PSMA-617 Targeted Radioligand Therapy In Metastatic Castration Resistant Prostate Cancer Receives FDA Clearance

  February 6, 2017

   · 

  4 min read
• Thermo Fisher Scientific Innovations Designed To Accelerate Research, Productivity And Discovery On Display At SLAS 2017

  February 6, 2017

   · 

  5 min read
• Thermo Fisher Scientific Release: New Comprehensive LC-MS Workflow Provides Researchers With Higher Quality Data For Clinical Research Samples

  February 6, 2017

   · 

  3 min read
• Business

  BioTime Expands Ophthalmology Portfolio With Global In-Licensing Agreement For Next-Generation Retinal Disease Therapy From University of Pittsburgh Medical Center

  February 6, 2017

   · 

  4 min read
• Bio NC

  3 Reasons TransEnterix Stock Could Fall

  February 6, 2017

   · 

  1 min read
• Bio NC

  Medical Tech Or Personal Touch? PeraHealth Has Cracked The Code

  February 6, 2017

   · 

  1 min read
• Pharm Country

  4 Studies That Could Shake Up The Future Of Regeneration

  February 6, 2017

   · 

  1 min read
• Policy

  The March For Science In Washington Is Political Whether You Like It Or Not

  February 6, 2017

   · 

  1 min read